Teal Health Secures $22M for At-Home HPV Cervical Cancer Screening Device

Posted
The Series A round was led by .406 Ventures, with support from Emerson Collective (managed by Yosemite), Forerunner, Serena Ventures and Japan-based MPower Partners. The post Teal Health Secures $22M for At-Home HPV Cervical Cancer Screening Device appeared first on MedCity News.

Continue reading at MedCity News »

Devices & Diagnostics, Health Tech, SYN, Top Story, cervical cancer, Teal Health